| Literature DB >> 32663196 |
Hideyuki Takeshima1, Tohru Niwa1, Satoshi Yamashita1, Takeji Takamura-Enya2, Naoko Iida1, Mika Wakabayashi1, Sohachi Nanjo3, Masanobu Abe4,5, Toshiro Sugiyama3, Young-Joon Kim6, Toshikazu Ushijima1.
Abstract
Chronic inflammation is deeply involved in various human disorders, such as cancer, neurodegenerative disorders, and metabolic disorders. Induction of epigenetic alterations, especially aberrant DNA methylation, is one of the major mechanisms, but how it is induced is still unclear. Here, we found that expression of TET genes, methylation erasers, was downregulated in inflamed mouse and human tissues, and that this was caused by upregulation of TET-targeting miRNAs such as MIR20A, MIR26B, and MIR29C, likely due to activation of NF-κB signaling downstream of IL-1β and TNF-α. However, TET knockdown induced only mild aberrant methylation. Nitric oxide (NO), produced by NOS2, enhanced enzymatic activity of DNA methyltransferases (DNMTs), methylation writers, and NO exposure induced minimal aberrant methylation. In contrast, a combination of TET knockdown and NO exposure synergistically induced aberrant methylation, involving genomic regions not methylated by either alone. The results showed that a vicious combination of TET repression, due to NF-κB activation, and DNMT activation, due to NO production, is responsible for aberrant methylation induction in human tissues.Entities:
Keywords: Epigenetics; Oncology
Year: 2020 PMID: 32663196 PMCID: PMC7524486 DOI: 10.1172/JCI124070
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808